Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Fierce Pharma
Karyopharm files Chapter 11 ahead of Ayrmid merger
The post-bankruptcy merger offers the struggling Karyopharm a way to keep its blood cancer pipeline alive.
Donavyn Coffey
Nov 2, 2026 10:46am
Biossil snags Theriva's antibiotic degraders in $91M deal
Nov 2, 2026 9:51am
Lower dose of Tiziana CD3 drug hits MS goal, unlike higher dose
Nov 2, 2026 8:37am
InventisBio’s ph. 3 psoriasis win yields competitive TYK2 data
Nov 2, 2026 6:30am
Gilead reveals partial clinical hold on 2 CAR-T trials
Oct 30, 2026 10:04am
Jazz's Actio buyout gives rise to Setara with $90M series A
Oct 30, 2026 6:30am